NANOGP8 and prostate carcinoma: Our results indicate that NANOG1 and NANOGP8 are expressed equally and that both genes activate many properties that are associated with the malignant potential in prostate cancer cells, including sphere formation capacity, migration capability, drug resistance, and tumorigenic potential.